| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q3 2023 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Microsoft | 38 | Q3 2022 | 8.6% |
| Honeywell Int'l | 38 | Q3 2022 | 5.5% |
| Merck & Co. | 38 | Q3 2022 | 5.6% |
| Weyerhaeuser Co. | 38 | Q3 2022 | 4.8% |
| Cisco Systems | 38 | Q3 2022 | 5.3% |
| Johnson & Johnson | 38 | Q3 2022 | 5.1% |
| Pfizer Inc. | 38 | Q3 2022 | 5.3% |
| International Paper | 38 | Q3 2022 | 4.6% |
| CVS Health Corporation | 38 | Q3 2022 | 5.6% |
| Verizon Communications | 38 | Q3 2022 | 3.1% |
View SALEM CAPITAL MANAGEMENT INC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2022-11-29 |
| 13F-HR | 2022-07-27 |
| 13F-HR | 2022-04-07 |
| 13F-HR | 2022-01-18 |
| 13F-HR | 2021-10-12 |
| 13F-HR | 2021-07-13 |
| 13F-HR | 2021-04-15 |
| 13F-HR | 2021-01-12 |
| 13F-HR | 2020-10-13 |
| 13F-HR | 2020-07-20 |
View SALEM CAPITAL MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.